硝基磺酚C光度法测定蛋白质的研究

蛋白质的定量分析是生化研究、临床化验和食品检验等领域经常涉及的内容.以有机小分子作光谱探针测定蛋白质,如甲基橙^[1,2]、考马斯亮蓝G-250^[3]、溴酚蓝^[4]、溴甲酚绿^[5]和偶氮胂Ⅲ^[6]等已得到研究.     

静电纺丝法制备NiO纳米纤维及其表征

纳米级NiO因具有优良的催化和热敏等性能而被广泛用于催化剂^[1]、电池电极^[2,3]、光电转化材料^[4～6]、电化学电容器^[7～8]等诸多方面.迄今,已成功地制备出N iO的纳米颗粒^[9]、纳米线^[10]及纳米薄膜^[11],但是对于具有准一维结构的NiO纳米纤维的制备及性能研究尚未见报道.     

膜乳化-液中干燥法制备单分散高分子微球

粒径可控的单分散高分子微球,在分析化学中可用作高效液相色谱填料^[1,2];在化学工业中可用作催化剂载体;在生物领域中用于药物释放、癌症与肝炎等临床诊断、细胞标记与识别等^[3].高分子微球的制备方法大致可分为两类,一是利用由单体出发的聚合反应或缩聚反应形成微球,二是高分子溶液经物理或物理化学手段处理后形成微球^[4]     

掺杂态聚苯胺蜂窝状有序多孔薄膜的制备及形成机制的探讨

近年来,由于微米、亚微米及纳米级有序多孔结构薄膜可以用于催化、生物培养基材、分离或吸附介质、光子晶体等诸多方面从而引起了科学家们极大的研究兴趣^[1～6].微制作是使材料表面具有新性能的重要手段,激光刻蚀及其相关技术已经被应用于不同表面的微图案化和微器件的制作^[7],另外,还可通过自组装技术进行多孔薄膜的制备^[8,9].Francois等^[10]于1994年首次提出了水辅助方法(Water-A ssisted Fab-rication),即在高湿度的环境下,以冷凝水滴为模板,在固体基片上制备了孔径分布均一,排列紧密的蜂窝状有序多孔薄膜.继而人们对此方法做了进一步的研究,不仅突破了最初的聚苯乙烯及其共聚物体系^[10～13],而且使用双亲共聚物^[14]、聚离子复合物^[15]和TiO₂前驱体的混合物^[16]等成功地获得了蜂窝状有序多孔薄膜,同时系统地研究了成膜体系及成膜条件对形成蜂窝状有序多孔薄膜的影响,并对形成机制进行了探讨.聚苯胺是典型的导电高分子,有关聚苯胺有序多孔结构薄膜的研究已有报道^[17～19].本文采用水辅助方法,在高湿度环境下,使用4-十二烷基苯磺酸掺杂的聚苯胺(PANI-DBSA)为成膜材料,制备了双层蜂窝状有序多孔薄膜,并通过原子力显微镜(A FM)对薄膜的形貌和电学性质进行了表征.同时在已有成膜机制的基础上,提出了该双层蜂窝状有序多孔薄膜的形成机制.     

微流控芯片液-液萃取-气相色谱联用系统的研究

微流控芯片多相层流技术自Yager等^[1]首次报道以来,已广泛应用于芯片上无膜渗析、过滤和萃取等前处理过程.2000年,Kitamori等^[2]报道了基于多相层流原理的芯片上液-液萃取系统,利用在微通道内形成并行流动的有机相和水相层流体系,通过溶质在液流间的分子扩散作用完成无膜的萃取分离操作.     

四(4-重氮基苯基)卟啉的合成及其与聚苯乙烯磺酸钠自组装的研究

卟啉是一类重要的功能性小分子染料,近年来,在光化学治疗^[1,2]、光电转换^[3,4]、传感元件^[5]、烯烃环氧化催化剂^[6]和光敏化剂^[7]等方面的研究与应用引起了人们的广泛注意.通过两亲卟啉分子衍生物,或带有负电荷的卟啉衍生物,特别是带磺酸基的卟啉分子与正离子聚电解质自组装,制备带有卟啉结构单元的LB膜和自组装膜已有很多报道^[8～14].     

Enterococcus durans产胞外多糖EPS-Ⅰ的分离纯化和结构分析

乳酸菌(LAB)作为对人类健康有益的食品级微生物正日益受到国内外科研工作者的关注.乳酸菌所产胞外多糖(EPS)即是LAB在生长代谢过程中分泌到细胞壁外的粘液多糖或荚膜多糖.不同种类的LAB所产的胞外多糖也不同,其结构变化多样,生物活性与其空间结构、分子量、分支度和溶解度有密切关系^[1,2].近年来国外有报道分离得到具有抗肿瘤和抗炎活性的乳酸菌EPS-Ⅰ^[3,4],但是国内对乳酸菌所产胞外多糖的研究尚未见报道.本实验从鸡肠道中的一株乳酸菌Enterococcus durans的发酵液中分离纯化得到一种具有免疫活性的胞外多糖EPS-Ⅰ^[5,6],通过化学和光谱分析证明它是由葡萄糖和甘露糖组成的五糖重复单元聚合的多糖,同时得出EPS2的五糖重复单元结构.     

Micro-DPIV技术在微型无阀泵瞬变流场检测中的应用

微型泵作为微流动系统的动力源,是微流动系统发展水平的重要标志.其中微型无阀泵以其结构简单、加工成本低而备受关注,同时该微泵可以进行生物大分子类流体的输送,因此在生化检测和药物控释等领域具有较强的集成应用价值^[1].     

用短毛细管柱分离一、二、三硝基甲苯的异构体

一、二、三硝基甲苯(简称MNT、DNT和TNT)共有15个异构体.分离这些异构体文献中虽有一些报道^[1-9],但均不太完善.我们曾用液晶填充柱分离和测定MNT的三个异构体[10];用OV-225填充柱分离DNT的六个异构体^[11];用OV-25和OV-210混合固定液填充柱分离TNT六个异构体^[12].     

茜素红S螯合树脂分离富集测定地质样品中的痕量金、铂和钯

用螯合树脂对金属进行分离富集及测定,前人已做了许多有意义的研究^[1～4].曾用含键合S双硫腙(P-D)和脱氢双硫腙(P-DT)功能团的离子交换树脂和螯合树脂分离金和铂族金属^[5],用双硫腙负载树脂分离富集Cu(Ⅱ)^[6]。     

壳聚糖溶液pH对载细胞海藻酸钠-壳聚糖微胶囊性能的影响

以激光共聚焦扫描显微镜为研究手段, 原位直观地考察了在不同pH条件下聚电解质膜的络合程度和蛋白扩散情况. 通过分析pH值对微胶囊膜性能的影响规律, 并结合不同种类细胞对环境pH的敏感特性, 确定了制备细胞培养用海藻酸钠-壳聚糖微胶囊的最佳pH值. 结果表明, 当壳聚糖溶液的pH值由3.50增加到6.50, 微胶囊膜的络合深度呈现高-低-高的趋势, 而微胶囊膜的膨胀性能呈现低-高-低的趋势, 模型蛋白通过微囊膜的扩散呈现低-高-低的趋势, 拐点均出现在pH=4.00和5.50处. 结合动物细胞及微生物细胞对环境pH耐受能力的考察, 确定制备微囊化动物细胞时, 微胶囊成膜反应溶液的最佳pH值为5.50; 制备微囊化大肠杆菌时, 反应溶液的最佳pH值为5.00; 制备微囊化酵母菌时, 反应溶液的最佳pH值为4.50.     

新型聚乙烯醇微囊的制备及其结构性能研究

采用低温物理交联法制备新型聚乙烯醇微囊,所得微囊机械强度好,克服了目前普遍采用的海藻酸钠-聚赖氨酸-海藻酸钠(APA)微囊易碎的缺点,在APA微囊已完全破碎的机械强度下,聚乙烯醇微囊的破碎率仅为3%.在体外模拟肠胃生理极限条件下可保持稳定的物理化学性质,对尿素、尿酸和肌酐等小分子具有良好的通透性,能在10min内完全通透.将高效分解尿素的脲酶基因工程菌E.coliDH5包埋于聚乙烯醇微囊之中,其工程菌仍具有很高的分解尿素能力,其活力约为自由菌的80%.     

Preparation of monodisperse crosslinked polymelamine microcapsules by phase separation method

Monodisperse polymelamine microcapsules were prepared by phase separation method. Control of microcapsule diameter was investigated using the uniform-sized oil-in-water emulsion droplets as the capsule core. The monodisperse emulsion droplets were prepared using the Shirasu porous glass (SPG) membrane emulsification technique. The effects of the diameter of the oil droplet and concentration of sodium dodecyl sulfate (SDS), which is a typical emulsifier in SPG membrane emulsification, on microencapsulation were investigated. The microcapsules were aggregated when oil droplets with small size were microencapsulated at high SDS concentration. To reduce the SDS concentration, the creamed emulsion was used. The monodisperse polymelamine microcapsules were successfully prepared by using the creamed emulsion. The microcapsule diameter was almost similar to the diameter of the encapsulated oil droplet. The coefficient of variation values was about 10% for all microcapsules prepared in this study. Control of microcapsule diameter was achieved in the range of 5–60 μm.     

以聚乙烯醇为载体制备微囊化脲酶基因工程菌的研究

研究了以聚乙烯醇为载体制备微囊化脲酶基因工程菌的方法。结果表明：微囊制备的适宜条件是聚乙烯醇(平均聚合度为2450)浓度为6％(w／v)，海藻酸钠添加量为0．1％，气流量为3L／min，射流量为1ml／10min，包菌量为8％(w／v)，反应时间24h，交联剂为含2％CaCl2的饱和硼酸溶液，并用Na2CO3调节pH值到6．5，在该条件下制备出的微囊细胞平均粒径为18-20mesh，机械强度远远高于对照组APA微囊，其细胞酶活性较未包埋的游离细胞略有下降。     

Preparation and Release Behavior of Ethylcellulose Microcapsules Containing Theophylline Dispersed in Cellulose Triacetate Matrices

Using ethylcellulose and cellulose triacetate as co-wall materials, sustained release microcapsules of theophylline were prepared. The solid drug dispersed in the cellulose triacetate matrices was first prepared by solvent evaporation; then the matrices were microencapsulated by means of coacervation-phase separation of ethylcellulose from toluene solution on addition of petroleum ether. The shapes and surface characteristics of theophylline, matrices and microcapsules were examined with a scanning-electron microscope. The release of theophylline from various particles into distilled water was studied. The microcapsules had good characteristics of sustained release. The period for theophylline to dissolve from ethylcellulose microcapsules containing cellulose triacetate matrices was larger than those from only ethylcellulose microcapsules with a similar ratio of core to wall. The half-time increased with increasing content of cellulose triacetate. The release pattern which was analogous to that from only ethylcellulose microcapsules obeyed a first-order equation.     

Supercooling Suppression of Microencapsulated n-Alkanes by Introducing an Organic Gelator

Supercooling of the microencapsulated phase change materials(PCMs) during cooling usually happens. This phenomenon can interfere with heat transfer and is necessary to further overcome. In this study, melamine- formaldehyde microcapsules containing two n-alkane PCMs, namely, n-dodecane(C₁₂) or n-tetradecane(C₁₄) were prepared by in situ polymerization. A small amount of n-hexatriacontane(C₃₆) was introduced as an organic gelator into the core of microcapsules to cope with the supercooling problem. Analyses demonstrate that supercooling of the microencapsulated C₁₂ or C₁₄ was significantly suppressed by adding 3%(mass fraction) C₃₆, without changing the spherical morphology and dispersibility. It could be also found that the enthalpy of microencapsulated C₁₂ or C₁₄ containing C₃₆ was similar to that of microencapsulated n-alkanes without C₃₆, whereas the difference between onsets of crystallization and melting(degree of supercooling) is similar to that of those of pure n-alkanes, suggesting the remarkable suppression ability of the organic gelator on supercooling.     

Purification of humanized monoclonal antibody by hydrophobic interaction membrane chromatography

Humanized monoclonal antibodies (mAbs) hold significant promise as biopharmaceuticals. One of the main challenges faced in the purification of mAbs is their separation from bovine serum albumin, which is the main protein present in most mammalian cell culture media. This paper discusses the purification of humanized mAb hIgG1-CD4 from CHO cell culture media by hydrophobic interaction membrane chromatography using a stack of microporous synthetic membranes. The effects of solution conditions on mAb solubility and binding on the membrane were first studied. The separation of a simulated mixture of bovine albumin and the mAb was then carried out to examine the feasibility of mAb purification. Separation experiments carried out under optimized conditions demonstrated that this membrane-based technique could be used for mAb purification from cell culture media. High purity (97%) and recovery (in excess of 97%) were obtained.     

磁性微胶囊的制备及其药物缓控释性能

用乳液-凝胶法制备了磁性壳聚糖/海藻酸钠微胶囊. 在壳聚糖/海藻酸钠微胶囊中掺入Fe3O4磁性中空球, 使微胶囊具有磁靶向性能. 以头孢拉定作为模型药物研究了载药磁性微胶囊的载药量、包封率及药物缓控释性能等. 结果表明, 提高头孢拉定的初始浓度可以提高载药量, 却不利于提高药物的包封率. 所制备的微胶囊在各种缓冲溶液中长时间内具有显著的缓释效果, 并具有pH 刺激响应释放的性能, 即在模拟胃液中的药物释放率大大降低, 而在模拟体液和肠液中的释放时间大大延长, 可达50 h以上. 另外, 在外加磁场作用下, 微胶囊表现出良好的磁定向运动性能, 为磁靶向药物输送提供基础.     

Multicore-shell PNIPAm-co-PEGMa microcapsules for cell encapsulation

The overall goal of this study was to fabricate multifunctional core-shell microcapsules with biological cells encapsulated within the polymer shell. Biocompatible temperature responsive microcapsules comprised of silicone oil droplets (multicores) and yeast cells embedded in a polymer matrix (shell) were prepared using a novel microarray approach. The cross-linked polymer shell and silicone multicores were formed in situ via photopolymerization of either poly(N-isopropylacryamide)(PNIPAm) or PNIPAm, copolymerized with poly(ethylene glycol monomethyl ether monomethacrylate) (PEGMa) within the droplets of an oil-in-water-in-oil double emulsion. An optimized recipe yielded a multicore-shell morphology, which was characterized by optical and laser scanning confocal microscopy (LSCM) and theoretically confirmed by spreading coefficient calculations. Spreading coefficients were calculated from interfacial tension and contact angle measurements as well as from the determination of the Hamaker constants and the pair potential energies. The effects of the presence of PEGMa, its molecular weight (M(n) 300 and 1100 g/mol), and concentration (10, 20, and 30 wt %) were also investigated, and they were found not to significantly alter the morphology of the microcapsules. They were found, however, to significantly improve the viability of the yeast cells, which were encapsulated within PNIPAm-based microcapsules by direct incorporation into the monomer solutions, prior to polymerization. Under LSCM, the fluorescence staining for live and dead cells showed a 30% viability of yeast cells entrapped within the PNIPAm matrix after 45 min of photopolymerization, but an improvement to 60% viability in the presence of PEGMa. The thermoresponsive behavior of the microcapsules allows the silicone oil cores to be irreversibly ejected, and so the role of the silicone oil is 2-fold. It facilitates multifunctionality in the microcapsule by first being used as a template to obtain the desired core-shell morphology, and second it can act as an encapsulant for oil-soluble drugs. It was shown that the encapsulated oil droplets were expelled above the volume phase transition temperature of the polymer, while the collapsed microcapsule remained intact. When these microcapsules were reswollen with an aqueous solution, it was observed that the hollow compartments refilled. In principle, these hollow-core microcapsules could then be filled with water-soluble drugs that could be delivered in vivo in response to temperature.     

Application of high-performance liquid chromatography to the purification of the putative intestinal peptide transporter

A membrane protein of relative molecular mass (Mr) 127,000 was identified by photoaffinity labelling as (a component of) the uptake system for small peptides and beta-lactam antibiotics in rabbit small intestine. This binding protein is a microheterogeneous glycosylated integral membrane protein which could be solubilized with non-ionic detergents and enriched by lectin affinity chromatography on wheat germ lectin agarose. For the final purification of this protein and separation from aminopeptidase N of Mr 127,000, fast protein liquid chromatography (FPLC) was used. Gel permeation, hydroxyapatite and hydrophobic interaction chromatography were not successful for the purification of the 127,000-dalton binding protein. By anion-exchange chromatography on a Mono Q column with either Triton X-100 or n-octylglucoside as detergent, a partial separation of the 127,000-dalton binding protein from aminopeptidase N was achieved. By cation-exchange chromatography on a Mono S HR 5/5 column at pH 4.5 using Triton X-100 as detergent also only a partial separation from aminopeptidase N could be achieved. If, however, Triton X-100 was replaced with n-octylglucoside, the binding protein for beta-lactam antibiotics and small peptides of Mr 127,000 could be completely separated from aminopeptidase N. These results indicate that Triton X-100 should be avoided for the purification of integral membrane proteins because mixed protein-detergent micelles of high molecular weight prevent a separation into the individual membrane proteins. The putative peptide transport protein was finally purified by rechromatography on Mono S and was obtained more than 95% pure as determined densitometrically after sodium dodecyl sulphate gel electrophoresis. By application of FPLC even microheterogeneous membrane glycoproteins from the intestinal mucosa can be purified to such an extent that a sequence analysis and immunohistochemical localization with antibodies prepared from the purified protein is possible.